MNG
DGX icon

Manning & Napier Group’s Quest Diagnostics DGX Stock Holding History

Manning & Napier Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4.93M Sell
37,061
-3,170
-8% -$411K 0.06% 173
2023
Q4 		$5.55M Sell
40,231
-7,923
-16% -$1.04M 0.07% 169
2023
Q3 		$5.87M Sell
48,154
-1,510
-3% -$201K 0.07% 167
2023
Q2 		$6.98M Buy
49,664
+4,863
+11% +$670K 0.08% 163
2023
Q1 		$6.34M Sell
44,801
-110
-0.2% -$15.7K 0.07% 190
2022
Q4 		$7.03M Sell
44,911
-973
-2% -$140K 0.09% 182
2022
Q3 		$5.63M Sell
45,884
-686
-1% -$90.3K 0.07% 204
2022
Q2 		$6.19M Sell
46,570
-26,447
-36% -$3.6M 0.07% 198
2022
Q1 		$9.99M Sell
73,017
-2,705
-4% -$377K 0.1% 179
2021
Q4 		$13.1M Sell
75,722
-4,691
-6% -$714K 0.11% 160
2021
Q3 		$11.7M Sell
80,413
-1,112
-1% -$163K 0.1% 165
2021
Q2 		$10.8M Buy
81,525
+28,511
+54% +$3.73M 0.09% 180
2021
Q1 		$6.8M Buy
53,014
+703
+1% +$86.6K 0.06% 208
2020
Q4 		$6.23M Buy
52,311
+3,643
+7% +$444K 0.06% 206
2020
Q3 		$5.57M Buy
48,668
+101
+0.2% +$11.9K 0.06% 204
2020
Q2 		$5.53M Sell
48,567
-4,596
-9% -$487K 0.06% 198
2020
Q1 		$4.27M Buy
53,163
+8,303
+19% +$860K 0.05% 197
2019
Q4 		$4.79M Buy
44,860
+1,647
+4% +$172K 0.05% 206
2019
Q3 		$4.62M Sell
43,213
-79
-0.2% -$8.11K 0.05% 219
2019
Q2 		$4.41M Buy
43,292
+10,067
+30% +$967K 0.05% 220
2019
Q1 		$2.99M Buy
33,225
+10,891
+49% +$944K 0.03% 237
2018
Q4 		$1.86M Buy
22,334
+2,415
+12% +$226K 0.02% 261
2018
Q3 		$2.15M Buy
19,919
+3,099
+18% +$340K 0.02% 264
2018
Q2 		$1.85M Buy
+16,820
New +$1.75M 0.02% 269

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Manning & Napier Group's DGX Position: Q1 2024 in Review

Manning & Napier Group reduced its Quest Diagnostics (DGX) stake by 7.9% in Q1 2024, selling an estimated $411K and leaving 37,061 shares worth $4.93M. The position accounts for 0.06% of the portfolio, ranked #173.

Manning & Napier Group first reported a position in DGX in Q2 2018 and has held it in 24 quarters since. The position peaked at $13.1M in Q4 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Manning & Napier Group held 37,061 shares of Quest Diagnostics worth $4.93M as of Q1 2024.
  • Manning & Napier Group sold 3,170 Quest Diagnostics shares in Q1 2024, an estimated $411K.
  • Quest Diagnostics made up 0.06% of Manning & Napier Group's portfolio in Q1 2024, its #173 holding.
  • Manning & Napier Group first reported a position in Quest Diagnostics in Q2 2018 and has held it in 24 quarters since.
  • Manning & Napier Group's Quest Diagnostics position peaked at $13.1M in Q4 2021.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.